Condition-specific dosing for XARELTO®
The Dosing Guide is a comprehensive resource that provides direction on how to properly dose XARELTO® based on the patient’s condition.
The Dosing Guide also covers bleed risk, switching patients to and from XARELTO®, temporary discontinuation, administration, pharmacological profile, and guideline recommendations.
◇For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
CAD = coronary artery disease; CrCl = creatinine clearance; CV = cardiovascular; DVT = deep vein thrombosis; NVAF = nonvalvular atrial fibrillation; PAD = pulmonary artery disease; PE = pulmonary embolism; VTE = venous thromboembolism.